SVMPharma Logo
  • Home
  • Our Services
    • Real World Evidence
    • Oncology Electronic Prescribing Records – RWE
    • RWE OUTCOMES
    • Global RWE
    • Additional Services
  • Resource Centre
  • About Us
  • Contact Us
Home / NHS England endorses Real World Evidence for the Cancer Drugs Fund and NICE

NHS England endorses Real World Evidence for the Cancer Drugs Fund and NICE

thumbnail CDF NICE

23rd July NHS Board Paper Thumbnail

Posted in Blogs.

Post navigation

← Real World Evidence – Patient…
Real World Evidence Making Headlines →

Click here to subscribe to SVMPharma’s RWE updates

Latest Updates

  • Adjuvant immunotherapy conferred a 93% survival at 1 year for patients with resectable melanoma at the highest risk of relapse
  • NICE funding impacts treatment sequencing patterns in chronic myeloid leukaemia (CML)
  • Use of real-world evidence to create standardised treatment pathways is essential for the future of oncology
  • FDA COVID-19: new real-world evidence data collection
  • Real-world data to combat COVID-19

Archives

  • July 2020 (3)
  • June 2020 (4)
  • May 2020 (4)
  • April 2020 (3)
  • March 2020 (4)
  • February 2020 (3)
  • January 2020 (4)
  • December 2019 (2)
  • November 2019 (3)
  • October 2019 (5)
  • September 2019 (3)
  • August 2019 (2)
  • July 2019 (5)
  • June 2019 (3)
  • May 2019 (2)
  • April 2019 (2)
  • March 2019 (2)
  • February 2019 (1)
  • January 2019 (1)
  • December 2018 (3)
  • November 2018 (2)
  • October 2018 (2)
  • September 2018 (1)
  • August 2018 (1)
  • April 2018 (1)
  • March 2018 (2)
  • February 2018 (2)
  • January 2018 (1)
  • November 2017 (2)
  • October 2017 (2)
  • September 2017 (3)
  • August 2017 (2)
  • July 2017 (3)
  • June 2017 (2)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (2)
  • February 2017 (2)
  • January 2017 (2)
  • December 2016 (1)
  • November 2016 (3)
  • October 2016 (3)
  • September 2016 (4)
  • August 2016 (2)
  • July 2016 (2)
  • June 2016 (5)
  • May 2016 (7)
  • April 2016 (4)
  • March 2016 (1)
  • February 2016 (2)
  • December 2015 (2)
  • November 2015 (3)
  • October 2015 (2)
  • September 2015 (1)
  • July 2015 (4)
  • June 2015 (2)
  • April 2015 (3)
  • March 2015 (3)
  • February 2015 (2)
  • January 2015 (1)

Quick Links

  • Real World Evidence
  • Global Real World Evidence
  • Additional Services
  • Privacy Policy
  • Contact Us

About SVMPharma

SVMPharma is a bespoke strategic consultancy based in Hampshire UK, specialising in Real World Evidence (RWE) for the pharmaceutical and healthcare industries. At SVMPharma we also cover Global RWE, Patient Experience, Big Data Analytics and Influence Mapping alongside Additional Services. Find further information and read our latest articles in the Resource Centre.

icon-phone +44 (0)1252 964650

Quick Links

  • Real World Evidence
  • Global Real World Evidence
  • Additional Services
  • Privacy Policy
  • Contact Us

Twitter

Tweets by @SVMPharma

RSS Latest News

  • Janssen's Tremfya wins psoriatic arthritis approval July 15, 2020
  • Radiotherapy in fewer doses safe for early breast cancer July 15, 2020
  • FDA committee backs GSK's multiple myeloma drug July 15, 2020
  • Study indicates lockdown significantly reduced coronavirus July 15, 2020
  • Tecentriq misses mark in ovarian cancer trial July 14, 2020
  • Privacy Policy
  • Website Disclaimer
  • Sitemap
© 2016 SVMPharma Ltd. All rights reserved.